Riddhi A Babel

4PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanotoxicology, health and safetyWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 20, 2026
Cost-effectiveness of pembrolizumab plus chemotherapy vs cemiplimab plus chemotherapy for first-line metastatic non-small cell lung cancer: a US payer perspective using a matching-adjusted indirect comparison.

Danmeng Huang, Ying Zhang, Riddhi A Babel

|Oct 17, 2025
5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC.

Stephen V Liu, Riddhi A Babel, Yu-Han Kao

|Apr 18, 2021
Stigma, HIV Risk, and Access to HIV Prevention and Treatment Services Among Men Who have Sex with Men (MSM) in the United States: A Scoping Review.

Riddhi A Babel, Peng Wang, Edward J Alessi

|Nov 25, 2020
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women.

Bo Qin, Riddhi A Babel, Jesse J Plascak

Pageof 1

Frequent Collaborators

1 joint publications

Bo Qin

1 joint publications

Jesse J Plascak

1 joint publications

Antoinette M Stroup

1 joint publications

Christine B Ambrosone